Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend Vial)

01 · At a glance

Quickstart Highlights

Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend) dosage protocol combines two growth-hormone–oriented peptides for research into lean muscle support, fat reduction, and potential metabolic improvements. Commonly dosed daily or 5 days per week for convenient scheduling Synergistic approach to stimulate growth hormone release Reconstitution volume typically 2–3 mL to maintain practical “units” Store lyophilized in the freezer; refrigerate after reconstitution Useful for examining combined effects on body composition

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Reference dose shown on this page: See guide.

Advanced / Aggressive Approach

Reconstitution Steps

1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
2. Inject water slowly along the vial wall to reduce foam formation.
3. Gently swirl—avoid vigorous shaking.
4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Investigate synergistic growth hormone support and body composition effects
• Schedule: Once daily or 5 days on, 2 days off for 8–12 weeks
• Dose Range: 300 mcg to 1 mg daily, depending on research objectives
• Reconstitution: 2–3 mL is most common (5 mg/mL or ~3.33 mg/mL)
• Storage: Keep lyophilized vials frozen and reconstituted solutions refrigerated

Dosing Protocol

• Reference dose shown on this page: See guide.
• With daily use at 500 mcg or higher, one 10mg vial may only last 10–20 days. Plan accordingly.
• If values change, rerun the calculator and update the protocol so future logs match the active plan.

Storage Instructions

• Review the source instructions and storage notes before handling any vial.
• Storage: Keep lyophilized vials frozen and reconstituted solutions refrigerated
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• Practical tips to enhance safety and consistency.
• Use new, sterile syringes for each injection; rotate injection sites.
• Track volume carefully; reconstitution volume dictates “units” per injection.
• Consult a qualified professional before adjusting dosage or if unusual reactions occur.
• Monitor progress throughout your research protocol, adjusting as indicated.

05 · How it works

How This Works

Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend) dosage protocol combines two growth-hormone–oriented peptides for research into lean muscle support, fat reduction, and potential metabolic improvements.

Commonly dosed daily or 5 days per week for convenient scheduling Synergistic approach to stimulate growth hormone release Reconstitution volume typically 2–3 mL to maintain practical “units” Store lyophilized in the freezer; refrigerate after reconstitution Useful for examining combined effects on body composition

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• Ipamorelin + Tesamorelin observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References